BACKGROUND: Welding exposes workers to manganese (Mn) fumes, but it is unclear if this exposure damages dopaminergic neurons in the basal ganglia and predisposes individuals to develop parkinsonism. PET imaging with 6-[(18)F]fluoro-l-dopa (FDOPA) is a noninvasive measure of nigrostriatal dopaminergic neuron integrity. The purpose of this study is to determine whether welding exposure is associated with damage to nigrostriatal neurons in asymptomatic workers. METHODS: We imaged 20 asymptomatic welders exposed to Mn fumes, 20 subjects with idiopathic Parkinson disease (IPD), and 20 normal controls using FDOPA PET. All subjects were examined by a movement disorders specialist. Basal ganglia volumes of interest were identified for each subject. The specific uptake of FDOPA, K(i), was generated for each region using graphical analysis method. RESULTS: Repeated measures general linear model (GLM) analysis demonstrated a strong interaction between diagnostic group and region (F(4,112) = 15.36, p < 0.001). Caudate K(i)s were lower in asymptomatic welders (0.0098 + 0.0013 minutes(-1)) compared to control subjects (0.0111 + 0.0012 minutes(-1), p = 0.002). The regional pattern of uptake in welders was most affected in the caudate > anterior putamen > posterior putamen. This uptake pattern was anatomically reversed from the pattern found in subjects with IPD. CONCLUSIONS: Active, asymptomatic welders with Mn exposure demonstrate reduced FDOPA PET uptake indicating dysfunction in the nigrostriatal dopamine system. The caudate K(i) reduction in welders may represent an early (asymptomatic) marker of Mn neurotoxicity and appears to be distinct from the pattern of dysfunction found in symptomatic IPD.
BACKGROUND: Welding exposes workers to manganese (Mn) fumes, but it is unclear if this exposure damages dopaminergic neurons in the basal ganglia and predisposes individuals to develop parkinsonism. PET imaging with 6-[(18)F]fluoro-l-dopa (FDOPA) is a noninvasive measure of nigrostriatal dopaminergic neuron integrity. The purpose of this study is to determine whether welding exposure is associated with damage to nigrostriatal neurons in asymptomatic workers. METHODS: We imaged 20 asymptomatic welders exposed to Mn fumes, 20 subjects with idiopathic Parkinson disease (IPD), and 20 normal controls using FDOPA PET. All subjects were examined by a movement disorders specialist. Basal ganglia volumes of interest were identified for each subject. The specific uptake of FDOPA, K(i), was generated for each region using graphical analysis method. RESULTS: Repeated measures general linear model (GLM) analysis demonstrated a strong interaction between diagnostic group and region (F(4,112) = 15.36, p < 0.001). Caudate K(i)s were lower in asymptomatic welders (0.0098 + 0.0013 minutes(-1)) compared to control subjects (0.0111 + 0.0012 minutes(-1), p = 0.002). The regional pattern of uptake in welders was most affected in the caudate > anterior putamen > posterior putamen. This uptake pattern was anatomically reversed from the pattern found in subjects with IPD. CONCLUSIONS: Active, asymptomatic welders with Mn exposure demonstrate reduced FDOPA PET uptake indicating dysfunction in the nigrostriatal dopamine system. The caudate K(i) reduction in welders may represent an early (asymptomatic) marker of Mn neurotoxicity and appears to be distinct from the pattern of dysfunction found in symptomatic IPD.
Authors: L Spahr; R F Butterworth; S Fontaine; L Bui; G Therrien; P C Milette; L H Lebrun; J Zayed; A Leblanc; G Pomier-Layrargues Journal: Hepatology Date: 1996-11 Impact factor: 17.425
Authors: Rüdiger Hilker; Christine Klein; Katja Hedrich; Laurie J Ozelius; Peter Vieregge; Karl Herholz; Peter P Pramstaller; Wolf Dieter Heiss Journal: Neurosci Lett Date: 2002-04-19 Impact factor: 3.046
Authors: P Piccini; P K Morrish; N Turjanski; G V Sawle; D J Burn; R A Weeks; M H Mark; D M Maraganore; A J Lees; D J Brooks Journal: Ann Neurol Date: 1997-02 Impact factor: 10.422
Authors: E C Wolters; C C Huang; C Clark; R F Peppard; J Okada; N S Chu; M J Adam; T J Ruth; D Li; D B Calne Journal: Ann Neurol Date: 1989-11 Impact factor: 10.422
Authors: Aaron B Bowman; Gunnar F Kwakye; Elena Herrero Hernández; Michael Aschner Journal: J Trace Elem Med Biol Date: 2011-10-01 Impact factor: 3.849
Authors: Junfeng Li; Xiang Zhang; Zhanbin Zhang; Prashanth K Padakanti; Hongjun Jin; Jinquan Cui; Aixiao Li; Dexing Zeng; Nigam P Rath; Hubert Flores; Joel S Perlmutter; Stanley M Parsons; Zhude Tu Journal: J Med Chem Date: 2013-07-18 Impact factor: 7.446
Authors: Susan R Criswell; Susan Searles Nielsen; Mark N Warden; Hubert P Flores; Jason Lenox-Krug; Sophia Racette; Lianne Sheppard; Harvey Checkoway; Brad A Racette Journal: J Occup Environ Med Date: 2019-08 Impact factor: 2.162
Authors: Susan R Criswell; Joel S Perlmutter; John L Huang; Nima Golchin; Hubert P Flores; Angela Hobson; Michael Aschner; Keith M Erikson; Harvey Checkoway; Brad A Racette Journal: Occup Environ Med Date: 2012-03-23 Impact factor: 4.402
Authors: Susan Searles Nielsen; Harvey Checkoway; Susan R Criswell; Federico M Farin; Patricia L Stapleton; Lianne Sheppard; Brad A Racette Journal: Parkinsonism Relat Disord Date: 2015-01-17 Impact factor: 4.891
Authors: Brad A Racette; Susan R Criswell; Jessica I Lundin; Angela Hobson; Noah Seixas; Paul T Kotzbauer; Bradley A Evanoff; Joel S Perlmutter; Jing Zhang; Lianne Sheppard; Harvey Checkoway Journal: Neurotoxicology Date: 2012-09-03 Impact factor: 4.294